30 closest matches · ranked by relevance
Drug Use Stigma in HIV Treatment Clinics
Primary: Modified Opening Minds Scale for Health Providers (OMS-HC) — 22.92; 16.82 score on a scale
HIV Infections · Stigmatization · Substance Use
Primary: Number of Participants Satisfied With the Intervention — 61; 0 Participants
Social Stigma · Substance Use Disorders · HIV Infections
Primary: Provider-based Stigma (Social Distance Scale (SDS) Measure) — 9.09; 11.89 score on a scale — p=<0.001
Opioid Use Disorder
Primary: Patient Internalized Stigma Towards Medicaid for Opioid Use Disorder (MOUDs) Over the Course of the Project — 15; 11; 14; 8 score on a scale — p=0.32
Alcohol or Other Drugs Use
Primary: Mean Number of Days Used Primary Drug (NumDU) — 8.5; 5.0 days
Substance-Related Disorders
Primary: Self-Report Receipt of HIV Test Results — 78; 338; 347 participants — p=<0.001
Substance-Related Disorders · Substance Use · Substance Use Disorders
Primary: Healthcare Worker Substance Use Stigma — 11.63; 9.95 score on a scale — p=0.023
Hiv
Primary: Acceptability of Intervention — 4.22; 4.72; 4.45 score on a scale
Mental and Behavioral Disorders Due to Harmful Drug Use
Primary: Total Number of Days of Primary Drug Used in the Prior 30 Days — 5.07; 3.61; 4.73 Days
Stigma, Social · Substance Use
Primary: Change in Stigma Resistance Scale (SRS) Score — 6.28 score on a scale
Substance-related Disorders
Primary: Change in Provision of Addiction Treatments — 66; 20; 268; 33 Participants — p=0.55
Stigma, Social · Opioid Use · Opioid-use Disorder
Primary: Enacted Stigma (Intrapersonal) — 0.730 score on a scale — p=0.252
Methamphetamine Abuse · Opioid-use Disorder · HIV Seropositivity
Primary: Increase in HIV Viral Suppression for HIV-positive Participants: High- vs. Low-Intensity Frontline Intervention With SMS in Stage 2 — 31; 35; 6; 3 Participants — p=0.447
Adherence · Depression · Heroin Dependence
Primary: Percent Medication Adherence at 3-month Follow-up Assessment — 79.02; 73.66 percent (doses taken/doses prescribed) — p=<.05
Substance Use Disorders · HIV · Depression
Primary: Change in Mental Health and Substance Use Screening Rates — 2008; 2379 Participants
Risk Behavior · Medication Adherence · HIV
Primary: Number of Participants in Each Condition With Optimal ART Adherence — 27; 29 participants
Substance-Related Disorders · Mental Disorder · Social Stigma
Primary: CHW Stigma Towards Substance Use — -0.88 change in units on a scale
Hepatitis C · Substance Use Disorders · Substance Abuse, Intravenous
Primary: SVR 12 — 24; 15; 47; 1 Participants
Hepatitis C · Opiate Dependence
Primary: Number of Participants With a Sustained Virologic Response (SVR) — 7; 1 participants
Hepatitis C · Medication Adherence
Primary: Sustained Viral Response (SVR) — 226; 236 participants
Hepatitis C · Medication Adherence
Primary: Electronically Monitored Medication Adherence — 86; 80; 75 Percentage of medication taken
Sexually Transmitted Infections
Primary: Number of Unprotected Acts of Intercourse — 19.7; 12.9; 18.2 # of unprotected sex acts at 12 months
Substance Use · HIV/AIDS · Older Adults
Primary: Number of Participants Ranking Intervention as Acceptable — 9; 5 Participants
HIV Infections
Primary: Adherence to Cabenuva Injections — 1; 17; 0; 1 Participants
Hiv · HIV Infections · AIDS
Primary: MSM Stigma; Domain of Care: Syphilis Testing — 0.078; 0.034 percentage points
HIV · Medication Adherence
Primary: Medication Adherence as Assessed by the Medication Event Monitoring System (MEMS) Cap — 52.2; 27.2 percentage of participants
Stigma, Social
Primary: Helpful/Empathetic Responses Toward Medial Mistrust in Hypothetical Patient Scenarios — 9.81; 9.26; 10.68; 8.90 score on a scale
HIV
Primary: Medication Adherence — 77.96; 80.13; 64.87; 76.13 Percentage of doses taken — p=.005
Opioid-use Disorder · Hiv
Primary: Number of Participants With HIV Viral Suppression, Missing Imputed as Unsuppressed — 23; 21; 29; 29 Participants
HIV · Stigma, Social · Self Efficacy
Primary: Number of Participants Recruited as Measured by Enrollment Logs — 80; 87 Participants